| Product NDC: | 51672-1304 |
| Proprietary Name: | Terconazole |
| Non Proprietary Name: | Terconazole |
| Active Ingredient(s): | 4 mg/g & nbsp; Terconazole |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51672-1304 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076043 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050119 |
| Package NDC: | 51672-1304-6 |
| Package Description: | 1 TUBE, WITH APPLICATOR in 1 CARTON (51672-1304-6) > 45 g in 1 TUBE, WITH APPLICATOR |
| NDC Code | 51672-1304-6 |
| Proprietary Name | Terconazole |
| Package Description | 1 TUBE, WITH APPLICATOR in 1 CARTON (51672-1304-6) > 45 g in 1 TUBE, WITH APPLICATOR |
| Product NDC | 51672-1304 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Terconazole |
| Dosage Form Name | CREAM |
| Route Name | VAGINAL |
| Start Marketing Date | 20050119 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | TERCONAZOLE |
| Strength Number | 4 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |